The six months expired in Oct 2015.GVHD had not received full marketing approval so there is one and the other is the first report of the phase 2 trial on rheumatoid arthritis which is due any day now!That's why they asked for a six month extension aswell as to do further due diligence on the applications.
The six months expired in Oct 2015.GVHD had not received full...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.943M | 3.695M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 19058 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 19794 | 7 |
View Market Depth
| Last trade - 12.36pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |